艾普尼美德 APMD
$15.10 +$0.94 (+6.64%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $15.10 0.00%
开盘$14.26
昨收$14.16
当日区间$14.11 – $15.41
成交量225.4K
市值$628.62M
市盈率（TTM）3.9
股息率–
APMD 相关新闻
匹配 Apnimed 或代码 APMD 的头条新闻，按最新排序。
- LifeSci Capital Maintains Apnimed(APMD.US) With Buy Rating, Maintains Target Price $50
- A Quick Look at Today's Ratings for Apnimed(APMD.US), With a Forecast Between $41 to $60
- Evercore Initiates Apnimed(APMD.US) With Buy Rating
- LifeSci Capital Initiates Apnimed(APMD.US) With Buy Rating, Announces Target Price $50
- BofA Securities Initiates Apnimed(APMD.US) With Buy Rating, Announces Target Price $41
- U.S. Stocks Move | Apnimed (APMD.US), a developer of drugs for sleep apnea, debuts on the U.S. stock market, with shares rising over 11% at the open. 正面
- BofA Securities Maintains Apnimed(APMD.US) With Buy Rating, Maintains Target Price $41
- Bank of America Securities Remains a Buy on Apnimed, Inc. (APMD)
暂无评论——快来第一个聊聊 APMD。
登录后参与讨论。